Enter your email address
Submit
Write your message
Volume 18, Issue 1 (Iranian Journal of Breast Diseases 2025)
ijbd 2025, 18(1): 119-132 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Maazil A A, Al-Saffar R S, Aljuburi D J, Mahdi H H, Nasrawi A J M. Breast Conservative Surgery Compared to Total Mastectomy for Breast Carcinoma in Terms of Postoperative Results, Quality of Life & Disease-Free Survival. ijbd 2025; 18 (1) :119-132
URL: http://ijbd.ir/article-1-1138-en.html
URL: http://ijbd.ir/article-1-1138-en.html
Ali Abbar Maazil1 
, Raad Saad Al-Saffar2 , Dhiaa Jabir Aljuburi1 , Hayder Hashim Mahdi3 
, Alaa Jumaah Manji Nasrawi *4
, Raad Saad Al-Saffar2 , Dhiaa Jabir Aljuburi1 , Hayder Hashim Mahdi3 , Alaa Jumaah Manji Nasrawi *4
1- Department of Surgery, University of Kufa, Faculty of Medicine, Iraq
2- Department of Surgery, Jaber Ibn Hayan University of Medical and Pharmaceutical Sciences, Faculty of Medicine, Iraq.
3- Department of Surgery, Al Najaf Health Directorate, Iraq
4- Department of Surgery, University of Kufa, Faculty of Medicine, Iraq ,alaaj.nasrawi@uokufa.edu.iq
2- Department of Surgery, Jaber Ibn Hayan University of Medical and Pharmaceutical Sciences, Faculty of Medicine, Iraq.
3- Department of Surgery, Al Najaf Health Directorate, Iraq
4- Department of Surgery, University of Kufa, Faculty of Medicine, Iraq ,
Abstract: (492 Views)
Introduction: Breast cancer is a prevalent global cancer, and surgery is vital for treatment. The debate between Breast-Conserving Surgery (BCS) and mastectomy has lasted for decades. This research aims to compare the quality of life, disease-free survival rates, and post-surgery outcomes of BCS and mastectomy in breast cancer patients.
Methodology: This retrospective study involved 100 women aged 18-80 years with non-metastatic breast cancer who underwent mastectomy or BCS between January 2019 and June 2024. Patient data were collected from hospital records. Quality of life was assessed using the Arabic EORTC QLQ-BR23 questionnaire, and cosmetic outcomes were evaluated with the Harris scoring scale. Disease-free survival was determined through a medical record review. Data analyses were conducted using the Student’s t-test and the Chi-square test.
Results: The BCS group demonstrated a significantly better body image than the mastectomy group (p< 0.01). The mastectomy group had a mean breast symptoms score of 48.5 compared to 62 for the BCS group. No significant differences were found between the groups concerning arm symptoms, hair loss upset, or systemic therapy's adverse effects. At 36 months post-surgery, disease-free survival rates were similar, with the mastectomy group at 87% and the BCS group at 82% (P=0.37).
Conclusions: The long-term disease-free survival rates for mastectomy and BCS are similar. However, BCS is associated with reduced breast-related discomfort and improved body image. This underscores the importance of tailoring care plans to the unique characteristics of each patient, tumor biology, and individual preferences, a responsibility that all healthcare providers should uphold.
Type of Study: Research |
Subject:
Diagnosis, treatment, rehabilitation
Received: 2024/09/18 | Accepted: 2025/01/14 | Published: 2025/03/19
Received: 2024/09/18 | Accepted: 2025/01/14 | Published: 2025/03/19
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021;71(3):209-49. doi: 10.3322/caac.21660. [DOI:10.3322/caac.21660] [PMID]
2. Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nature reviews Clinical oncology. 2021;18(10):663-72. doi.org/10.1038/s41571-021-00514-z [DOI:10.1038/s41571-021-00514-z] [PMID]
3. Allahqoli L, Mazidimoradi A, Momenimovahed Z, Rahmani A, Hakimi S, Tiznobaik A, et al. The global incidence, mortality, and burden of breast cancer in 2019: correlation with smoking, drinking, and drug use. Frontiers in oncology. 2022;12:921015. doi: 10.3389/fonc.2022.921015. [DOI:10.3389/fonc.2022.921015] [PMID] []
4. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine. 2002;347(16):1233-41. doi: 10.1056/NEJMoa022152. [DOI:10.1056/NEJMoa022152] [PMID]
5. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Annals of Oncology. 2001;12(7):997-1003. doi: 10.1023/a:1011136326943. [DOI:10.1023/A:1011136326943] [PMID]
6. National Cancer Institute. Breast cancer. National Cancer Institute; 2014 [cited 2024]; Available from: http://www.cancer.gov/cance rtopics/types/breast.
7. American Cancer Society. Breast cancer. American Cancer Society; 2014 [cited 2024]; Available from: http://www.cancer.org/cancer
8. /breastcancer/.
9. Flatley MJ, Dodwell DJ. Adjuvant treatment for breast cancer. Surgery (oxford). 2016; 34(1):43-6. [DOI:10.1016/j.mpsur.2015.10.003]
10. Maishman T, Cutress RI, Hernandez A, Gerty S, Copson ER, Durcan L, et al. Local recurrence and breast oncological surgery in young women with breast cancer: the POSH observational cohort study. Annals of surgery. 2017;266(1):165-72. doi: 10.1097/SLA. 0000000000001930. [DOI:10.1097/SLA.0000000000001930] [PMID] []
11. McEvoy MP, Landercasper J, Naik HR, Feldman S. Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic. Gland Surgery. 2018;7(6):536. doi: 10.21037/gs.2018.11.03. [DOI:10.21037/gs.2018.11.03] [PMID] []
12. American Cancer Society. Breast reconstruction after mastectomy. American Cancer Society,; 2014 [cited 2024]; Available from: http://www.cancer.org/cancer/ breastcancer/moreinformation/breastreconstru ctionaftermastectomy/index.
13. Harcourt DM, Rumsey NJ, Ambler NR, Cawthorn SJ, Reid CD, Maddox PR, et al. The psychological effect of mastectomy with or without breast reconstruction: a prospective, multicenter study. Plast Reconstr Surg. 2003 Mar;111(3):1060-8. doi: 10.1097/01.PRS.0000046249.33122.76. [DOI:10.1097/01.PRS.0000046249.33122.76] [PMID]
14. Burckhardt CS, Anderson KL. The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health and quality of life outcomes. 2003;1:1-7. doi.org/10.1186/1477-7525-1-60 [DOI:10.1186/1477-7525-1-60] [PMID] []
15. Dahlui M, Azzani M, Taib NA, Hoong SM, Jamaris S, Islam T. Breast conserving surgery versus mastectomy: the effect of surgery on quality of life in breast cancer survivors in Malaysia. BMC Women's Health. 2023;23(1):607. doi.org/10.1186/s12905-023-02738-w [DOI:10.1186/s12905-023-02738-w] [PMID] []
16. Jalil AT, Dilfi SH, Karevskiy A. Survey of Breast Cancer in Wasit Province, Iraq. Global Journal of Public Health Medicine. 2019; 1(2):33-8. doi:10.37557/GJPHM.V1I2.7 [DOI:10.37557/gjphm.v1i2.7]
17. Kwon D, Ko BK, Jung SP, Kim H-K, Kim E-K, Jung YS, et al. Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population. Plos one. 2022;17(1):e0262709. [DOI:10.1371/journal.pone.0262709] [PMID] []
18. Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, Rosner BA. Risk factors for ductal and lobular breast cancer: results from the nurses' health study. Breast Cancer Research. 2010;12:1-11. doi: 10.1186/bcr2790. [DOI:10.1186/bcr2790] [PMID] []
19. Kiang DT, Gay J, Goldman A, Kennedy BJ. A randomized trial of chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med. 1985 Nov 14;313(20):1241-6. doi: 10.1056/NEJM198511143132001. [DOI:10.1056/NEJM198511143132001] [PMID]
20. Afshar-Bakshloo M, Albers S, Richter C, Berninger O, Blohmer J-U, Roehle R, et al. How breast cancer therapies impact body image-real-world data from a prospective cohort study collecting patient-reported outcomes. BMC cancer. 2023;23(1):705. doi: 10.1186/s12885-023-11172-y. [DOI:10.1186/s12885-023-11172-y] [PMID] []
21. Song Y-C, Huang Z, Fang H, Tang Y, Jing H, Song Y-W, et al. Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy. Frontiers in oncology. 2023; 13:1178230. doi: 10.3389/fonc.2023.1178230. [DOI:10.3389/fonc.2023.1178230] [PMID] []
22. Ng ET, Ang RZ, Tran BX, Ho CS, Zhang Z, Tan W, et al. Comparing quality of life in breast cancer patients who underwent mastectomy versus breast-conserving surgery: a meta-analysis. International journal of environmental research and public health. 2019;16(24):4970. doi: 10.3390/ijerph16244970. [DOI:10.3390/ijerph16244970] [PMID] []
23. Simons JM, Jacobs JG, Roijers JP, Beek MA, Boonman-de Winter LJ, Rijken AM, et al. Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study. Breast Cancer Research and Treatment. 2021;185:441-51. doi:10.1007/s10549-020-05966-y. [DOI:10.1007/s10549-020-05966-y] [PMID] []
24. Christiansen P, Mele M, Bodilsen A, Rocco N, Zachariae R. Breast-conserving surgery or mastectomy?: impact on survival. Annals of Surgery Open. 2022;3(4):e205. doi: 10.1097/AS9.0000000000000205. [DOI:10.1097/AS9.0000000000000205] [PMID] []
25. Li S, Li X, L
26. Avci GG, Güney Y, Küçükpilakci B, Çalikoğlu T, Gülçelik MA, Özaslan C. Intraoperative radiotherapy with electrons as partial breast irradiation in limited stage breast cancer: Early term clinical and cosmetic outcomes. Journal of Cancer Research and Therapeutics. 2019;15(5):994-8. doi: 10.4103/jcrt.JCRT_191_17. [DOI:10.4103/jcrt.JCRT_191_17] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
